Using synthetic biocompatible polymers called hydrogels, researchers at the Georgia Institute of Technology have been able to induce significant vasculature growth in areas of damaged tissue.

They are currently studying the clinical viability of these hydrogels as therapeutic vascularization therapies to treat peripheral artery disease and ischemic heart disease, and cell transplantation to treat diabetes.